NIH-funded research R01 grant

Two-dimensional nanosilicates for delivering cartilage-building signals

Official title: Two-dimensional Nanosilicates for Transcription Factor Delivery

Funded at Texas Engineering Experiment Station · NIH-11306231 · Data updated 2026-11-12

A new biomaterial approach uses tiny layered minerals to deliver cartilage-building signals inside joints to help regenerate damaged cartilage from within.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionTexas Engineering Experiment Station
NIH-funded
Lab location1 site (College Station, United States)
Project startJune 1, 2026
Project endFebruary 28, 2030
Funding year2026
Award (this year)$483,246
NIH project number1R01EB037034-01A1
Project IDNIH-11306231 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are adults with symptomatic osteoarthritis affecting one or more joints where cartilage repair is a treatment goal.

Less likely to help

Patients with OA without cartilage defects or those not receiving intra-articular treatments may see limited benefit.

What this research studies

This project tests nanosilicates, a novel biomaterial, to enhance cartilage repair by delivering transcription factors that guide cartilage formation directly in the joint. It builds on the inventor’s patented technology and aims to find the best amount of nanosilicate material and how it interacts with joint tissue to support healing. The work will also compare how well this approach works in large-animal models to move toward real-world use in people with osteoarthritis.

Why it matters

Potential benefit: If successful, this approach could improve cartilage repair and reduce pain and mobility limits for people with osteoarthritis.

How similar studies have gone: Previous studies show nanosilicates can promote chondrogenic factors and enhance cartilage matrix production in early models, suggesting potential but requiring translation to larger animals.

Where this research is happening

  • Texas Engineering Experiment Station
    College Station, United States
    Active

Researchers

  • Principal investigator: Gaharwar, Akhilesh K. — Texas Engineering Experiment Station
  • Study coordinator: Gaharwar, Akhilesh K.

Related research

Other NIH-funded projects on the same topics.

  • Robotic dental implants to deliver stem cells

    A new wireless robotic implant approach aims to improve bone healing and implant stability by delivering stem cells directly at the implant site for people needing dental implants.

    NIH research Texas Engineering Experiment Station · College Station, United States · NIH-11591543

  • Digital Twin for Personalized Spine Fracture Prediction in Osteoporosis

    A patient-focused project that uses CT scans and a digital twin model to predict where an osteoporotic spine might fracture during everyday activities.

    NIH research Texas Engineering Experiment Station · College Station, United States · NIH-11577865

  • Nanoparticle therapy to reduce alcohol-related liver scarring and cancer risk

    This project is developing tiny particles that deliver anti-fibrotic medicine to livers damaged by heavy drinking to help reduce scarring and lower the chance of liver cancer.

    NIH research Texas Engineering Experiment Station · College Station, United States · NIH-11456681

  • Smart wrist wearable for continuous cuffless blood pressure and vital signs across diverse skin tones

    A wearable wrist device will continuously monitor blood pressure, heart rate, and breathing in adults of diverse skin tones and body types, using non-invasive sensors and smart algorithms.

    NIH research Texas Engineering Experiment Station · College Station, United States · NIH-11449053

  • Role of the Nucleus in YAP/TAZ Control in Head and Neck Cancer

    Aims to understand how changes in the cell nucleus influence YAP/TAZ pathways that drive head and neck cancer, with the hope of finding biomarkers for treatment response.

    NIH research Texas Engineering Experiment Station · College Station, United States · NIH-11448647

  • Targeted nanoparticle therapy for lung fibrosis

    A researcher team is testing inhaled nanoparticles that deliver medicine directly to the lungs to slow or stop scarring in people with pulmonary fibrosis.

    NIH research Texas Engineering Experiment Station · College Station, United States · NIH-11448075

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.